AC Immune SA
ACIU
$2.92
-$0.03-1.02%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.99M | -25.69M | -21.17M | -21.17M | -17.99M |
| Total Depreciation and Amortization | 819.90K | 755.20K | 680.80K | 680.80K | 602.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.26M | 3.01M | 2.11M | 2.11M | -1.32M |
| Change in Net Operating Assets | -4.75M | 3.01M | -2.55M | -2.55M | 25.46M |
| Cash from Operations | -20.66M | -18.91M | -20.93M | -20.93M | 6.76M |
| Capital Expenditure | -133.90K | -452.20K | -402.70K | -402.70K | -102.50K |
| Sale of Property, Plant, and Equipment | 0.00 | 18.20K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.17M | 29.39M | 3.77M | 3.77M | -4.25M |
| Cash from Investing | 20.03M | 28.95M | 3.37M | 3.37M | -4.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -260.00K | -255.00K | -253.00K | -253.00K | -171.00K |
| Issuance of Common Stock | -- | 3.00K | -- | -- | -- |
| Repurchase of Common Stock | -1.00K | -- | -- | -- | -25.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 5.00K | -5.00K | -5.00K | -1.00K |
| Cash from Financing | -326.70K | -299.40K | -287.00K | -287.00K | -224.30K |
| Foreign Exchange rate Adjustments | -225.30K | -2.76M | -299.20K | -299.20K | 2.22M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.18M | 6.99M | -18.15M | -18.15M | 4.39M |